NL-OMON45669已完成不适用
Pharmacokinetics of clindamycin in overweight patients - CLIPO
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •1. Age >18 years;
- •2. Treatment at regular dosing intervals with intravenous or oral clindamycin for at least 48 hours on day 0 (see Study procedures).;
- •3. Having signed the Informed Consent form.
排除标准
- •1. Administration of medication with a known pharmacokinetic interaction ( e.g. rifampicin, HIV protease inhibitors).;
- •2. Inability to understand the nature of the trial and the procedures required.;
- •3. Self-reported pregnancy.;
研究者
相似试验
招募中
不适用
Concentratie van clindamycine in bloed bij patiënten met overgewichtNL-OMON20286Gelre Hospitals, Apeldoorn/ZutphenAlbert Schweitzerlaan 31 7334 DZ Apeldoorn40
招募中
不适用
Obesity effect on the characteristics of the blood-thinning drug rivaroxabavenous thromboembolismobesityatrial fibrillationACTRN12622000297729Medical Research Center, Hamad Medical Corporation81
招募中
1 期
Clindamycin pharmacokinetics during obstetric or fetal surgeryProphylaxis (antibiotics) during maternal or fetal surgeryCTIS2023-503653-35-00Z Leuven
已完成
1 期
W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With AcneAcne VulgarisNCT01132443Stiefel, a GSK Company72
Unknown
不适用
Study of Obese Patients Comparing Two Vancomycin Loading Dose RegimensInfectionObesitySepsisNCT02764359CAMC Health System128